Company Profile
Grifols provides the research, development, production, and marketing of plasma-derived medicines globally. Its business is organized into four segments: Biopharma, Diagnostic, Bio Supplies, and Others.
The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas
Markets diagnostic testing equipment, reagents, and equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services, as well as biological products
Including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. Additionally, it provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients.
Its portfolio also includes high-tech solutions to automate hospital processes, clinical nutrition to deliver nutrition and medication, and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery Manufacturing services to third parties and research activities.
It also is involved in engineering services. Its portfolio also includes packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products, import, export, and commercialization activities, travel agency services, reinsurance of insurance policies, support services, law business, and consultation, administration, and financing services. Founded in 1909, the company is headquartered in Barcelona, Spain.